|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 325.90 CHF | -0.37% |
|
+4.97% | -0.34% |
| 11:03am | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 11:03am | Race to launch weight-loss pill heats up as Novo wins UK approval | RE |
Published on 06/04/2026 at 10:54 am EDT
ZURICH, June 4 (Reuters) - Roche Chairman Severin Schwan said on Thursday that protectionism by the United States and China is the biggest geopolitical concern occupying the Swiss drug maker.
Schwan was speaking at an event in Interlaken.
(Reporting by Oliver HirtEditing by Dave Graham)
Dr. Severin Schwan is a Vice President at International Federation of Pharmaceutical Manufacturers, a Vice Chairman at Credit Suisse Group AG, a Member of the Board of Directors at Credit Suisse AG, a Member at European Round Table of Industrialists, a Member at International Business Leaders Advisory Council, a Chairman at Roche Holdings, Inc., a Chief Executive Officer at Roche Group, a Chief Executive Officer & Executive Director at Roche Holding AG, a Chief Executive Officer & Director at F. Hoffmann-La Roche Ltd., a Chairman at Genentech, Inc., a Chairman at Roche Pharma Schweiz AG, a Chairman-Supervisory Board at Roche Diabetes Care GmbH, a Chairman-Supervisory Board at Roche Diagnostics Deutschland GmbH and a Chairman-Supervisory Board at Roche Pharma AG. He is on the Board of Directors at Credit Suisse Group AG, Credit Suisse AG, Roche Holding AG and F. Hoffmann-La Roche Ltd. Dr. Schwan was previously employed as a Chief Executive Officer by Roche Diagnostics Corp., a Head-Asia Pacific Region by Roche Diagnostics Asia Pacific Pte Ltd., a Head-Global Finance & Services by Roche Diagnostics AG, a Member-Executive Board by Roche Deutschland Holding GmbH, a Head-Finance & Administration by Roche (Brussels), and a Chairman-Member-Supervisory Board by Roche Diagnostics GmbH. He also served on the board at Credit Suisse (Schweiz) AG and Chugai Pharmaceutical Co., Ltd. He received his graduate degree from the University of Innsbruck and a doctorate degree from the University of Innsbruck.
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
